Swiss germ-cell cancer consensus recommendations.

Détails

ID Serval
serval:BIB_632D6763E6AD
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Swiss germ-cell cancer consensus recommendations.
Périodique
Swiss medical weekly
Auteur⸱e⸱s
Beyer J., Berthold D., Bode P.K., Cathomas R., Fankhauser C.D., Fischer S., Gillessen S., Gross T., Hermanns T., Honecker F., Lorch A., Omlin A., Papachristofilou A., Roth B., Rothermundt C., Seiler R., Spahn M., Stenner F., Bührer E.
ISSN
1424-3997 (Electronic)
ISSN-L
0036-7672
Statut éditorial
Publié
Date de publication
23/08/2021
Peer-reviewed
Oui
Volume
151
Numéro
33-34
Pages
w30023
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Résumé
Approximately 420 men are diagnosed with germ-cell cancer (GCC) in Switzerland each year. Recent international guidelines outline management issues, but many aspects remain controversial in an area of highly individualised treatments. Even more than in other tumour types, in GCC the challenge is to choose exactly the correct treatment for an individual patient. Overtreatment in patients likely to be cured must be avoided to reduce long-term toxicities. On the other hand, treatment intensification is required in patients presenting with adverse prognostic factors. Therefore, referral to expert centres or consultations with an expert for a second opinion is strongly recommended. In 2020, Swiss experts discussed their strategies in a consensus meeting during the virtual Swiss Oncology and Haematology Congress (SOHC) in order to harmonise their concepts and to suggest optimal strategies for the management of GCC patients in Switzerland. Votes on controversial issues were obtained and are presented in this review wherever applicable.
Pubmed
Open Access
Oui
Création de la notice
04/10/2021 13:13
Dernière modification de la notice
13/11/2021 7:36
Données d'usage